Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancer. Read more about Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancer.
Perturbations in common and distinct inflammatory pathways associated with morning and evening fatigue in outpatients receiving chemotherapy. Read more about Perturbations in common and distinct inflammatory pathways associated with morning and evening fatigue in outpatients receiving chemotherapy.
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance. Read more about Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.
Opportunities to use electronic health record audit logs to improve cancer care. Read more about Opportunities to use electronic health record audit logs to improve cancer care.
COVID-19 outcomes in patients with cancer: Findings from the University of California health system database. Read more about COVID-19 outcomes in patients with cancer: Findings from the University of California health system database.
Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High-intensity Aerobic and resistance exercise for Metastatic castrate-resistant Prostate cancer. Read more about Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High-intensity Aerobic and resistance exercise for Metastatic castrate-resistant Prostate cancer.
Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma. Read more about Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma.
Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma. Read more about Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma.
Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer. Read more about Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer.
Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies. Read more about Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies.
